The Japanese Society for Radiation Oncology ( JASTRO) Guidelines for Radiotherapy Treatment Planning have been revised every four years to incorporate the latest findings since the publication of the first edition in 2004. This is a review which presents the 2024 JASTRO Guidelines for radiotherapy treatment planning for esophageal cancer in English. Regarding the treatment of esophageal cancer, various new findings have emerged over the past 4 years, leading to significant updates in the 2020 edition, particularly in the following six areas: (i) additional details on indications for superficial cancer, (ii) inclusion of clinical trial results ( JCOG1109) for neoadjuvant chemotherapy and chemoradiotherapy in locally advanced cases in Japan, (iii) updated references on prophylactic lymph node irradiation, (iv) updates on IMRT, (v) revisions in accordance with the 5th edition of the Esophageal Cancer Treatment Guidelines, and (vi) additions of FOLFOX to concurrent chemotherapy regimens.

自2004年第一版发表以来，日本放射肿瘤学会（Japanese Society for Radiation Oncology，JASTRO）放射治疗计划指南每4年修订1次，以纳入最新研究结果。现对2024版JASTRO食管癌放疗计划指南进行综述。在食管癌治疗方面，过去4年出现了各种新发现，使2020版指南有了重大更新，特别是在以下6个领域：（i）增加浅表性癌症适应症的详细信息，（ii）包括日本当地晚期病例新辅助化疗和放化疗的临床试验结果（JCOG1109），（iii）更新关于预防淋巴结照射的参考文献，（iv）更新调强放疗，(v)根据第5版食管癌治疗指南的修订，（vi）结直肠癌联合方案在同步化疗方案中增加。